Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Clinical trial NCT07484217 · RECRUITING

Trial details

NCT number: NCT07484217
Sponsor: Axsome Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Start date: 2026-02-23
Primary completion: 2028-12-01
Enrollment: 508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.